norstella-logo-white

Redefining patient access strategy

Patient access continues to be a major hurdle in the US pharma industry, impacting the speed of drug development and therefore the delivery of life-saving treatments to patients. To assess the current state of patient access, Norstella’s Managed Markets Insight & Technology (MMIT) surveyed over 300 industry professionals on major trends and challenges in pharma and how they can be improved upon as the landscape continues to evolve. The following video highlights the survey’s key findings and how industry can use this data to inform their patient access strategy in the future.

Partnering with Norstella provides access to timely data and insights that allows industry players to stay ahead of the curve. If you would like to learn more about partnering with Norstella to optimize your approach to patient access, visit our solutions page.

The full, in-depth MMIT patient access report is also available online today!

Work with us

Join our mission

We’re looking for agile, growth-oriented team players who are passionate about client success and helping clients bring life-saving therapies to market quicker—and help patients in need.

Work with us

Get in Touch

Let's connect

Have questions about Norstella or its brands? Or do you want to know more about how to solve your challenges at each stage of the drug life cycle?

We want to hear from you